Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
Authors
Keywords
-
Journal
Journal of Fungi
Volume 7, Issue 6, Pages 440
Publisher
MDPI AG
Online
2021-06-01
DOI
10.3390/jof7060440
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program
- (2021) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
- (2021) Hiram Villanueva-Lozano et al. CLINICAL MICROBIOLOGY AND INFECTION
- Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples
- (2021) Juan V. Mulet Bayona et al. MYCOSES
- Candida auris: descripción de un brote
- (2020) Carme Salvador García et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
- (2020) Timothy M Rawson et al. CLINICAL INFECTIOUS DISEASES
- Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
- (2020) S. Hughes et al. CLINICAL MICROBIOLOGY AND INFECTION
- Incidence of co-infections and superinfections in hospitalised patients with COVID-19: a retrospective cohort study
- (2020) Carolina Garcia-Vidal et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID-19 and fungal co-infections: We must keep them in mind
- (2020) A. Agrifoglio et al. JOURNAL DE MYCOLOGIE MEDICALE
- Invasive fungal diseases during COVID-19: We should be prepared
- (2020) J.-P. Gangneux et al. JOURNAL DE MYCOLOGIE MEDICALE
- Fungal co-infection in COVID-19 patients: Should we be concerned?
- (2020) Javier Pemán et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic
- (2020) Anuradha Chowdhary et al. Journal of Global Antimicrobial Resistance
- Characteristics and Management of Candidaemia Episodes in an Established Candida auris Outbreak
- (2020) Juan V. Mulet Bayona et al. Antibiotics-Basel
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- Diagnosis and treatment of invasive fungal infections: looking ahead
- (2019) Maurizio Sanguinetti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Hidden Cost of Modern Medical Interventions: How Medical Advances Have Shaped the Prevalence of Human Fungal Disease
- (2019) Callum Clark et al. Pathogens
- Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
- (2019) Stefan Schwartz et al. MEDICAL MYCOLOGY
- Global epidemiology of emerging Candida auris
- (2019) Johanna Rhodes et al. CURRENT OPINION IN MICROBIOLOGY
- Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect
- (2018) Laura Judith Marcos-Zambrano et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Estimation of direct healthcare costs of fungal diseases in the United States
- (2018) Kaitlin Benedict et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
- (2016) George R. Thompson et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Antifungal stewardship in daily practice and health economic implications
- (2015) Patricia Muñoz et al. MYCOSES
- The clinical spectrum of pulmonary aspergillosis
- (2014) C. Kosmidis et al. THORAX
- Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Critically Ill Patients
- (2012) Élie Azoulay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients
- (2011) J. J. VEHRESCHILD et al. EPIDEMIOLOGY AND INFECTION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started